Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


International Brain Tumour Alliance


Address

c/o Roxburghe House
273-287 Regent Street
London, W1B 2AD United Kingdom

Phone

4401737813872

Fax

4401737812712

Description

The International Brain Tumour Alliance (IBTA) is a non-profit organization that seeks to achieve for brain tumour patients, their families and their caregivers a wider public recognition of the specific challenges which they face in dealing with their disease. It seeks to be an alliance of the support, advocacy and information groups for brain tumour patients and caregivers in different countries and also includes researchers, scientists, clinicians and allied health professionals who work in the area of brain tumours. IBTA advocates the development of improved access to a multi-disciplinary specialist range of services, including palliative care, rehabilitation (speech, neuropsychology, occupational therapy, physiotherapy, etc) and psychosocial support, to ensure that services are at all times appropriate to the needs of people living with a brain tumour and their families.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.